Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia

Leukemia Research

Volumn 23, Issue 11, 1999, Pages 975-981

  Sasai, Yuri ^a   Horiike, Shigeo ^a   Misawa, Shinichi ^b   Kaneko, Hiroto ^b   Kobayashi, Miyako ^a   Fujii, Hiroshi ^c   Kashima, Kei ^a   Taniwaki, Masafumi ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KYOTO FIRST RED CROSS HOSPITAL   (Japan)

Author keywords

Chromosomes; Genotype; Glutathione S transferase; Myelodysplasia; NRAS, TP53; Polymorphism; Therapy related leukemia

Indexed keywords

GLUTATHIONE TRANSFERASE;

ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEMATOLOGIC DISEASE; HUMAN; JAPAN; KARYOTYPE; LEUKEMIA; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MUTATION; MYELODYSPLASIA; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT;

ACUTE DISEASE; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LEUKEMIA, MYELOID; MYELODYSPLASTIC SYNDROMES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0032864243     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00119-8     Document Type: Article

References (36)

1. Levine E.G., Bloomfield C.D. Leukemias and myelodysplastic syndromes secondary to drug, radiation and environmental exposure. Semin. Oncol. 19:1992;47.
2. Farrow A., Jacobs A., West R.R. Myelodysplasia, chemical exposure and other environmental factors. Leukemia. 3:1989;33.
3. West R.R., Stanfford D.A., Farrow A., Jacobs A. Occupational and environmental exposures and myelodysplasia: a case-control study. Leuk. Res. 19:1995;127.
4. Aksoy M. Malignancies due to occupational exposure to benzene. Am. J. Med. 2:1985;217.
5. Idle J.R. Is environmental carcinogenesis modulated by host polymorphism? Mutat. Res. 247:1991;259.
6. Seidegard J., Pero R.W., Markowitz M.M., Roush G., Miller D.G., Beattie E.J. Isoenzymes of glutathione S-transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis. 11:1990;33.
7. Bell D.A., Taylor J.A., Paulson D.F., Robertson C.N., Mohler J.L., Lucier G.W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85:1993;1159.
8. Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinonenesis. Mutat. Res. 202:1988;343.
9. Mannervik B., Danielson U.H. Glutathione transferases: structure and catalytic activity. CRC. Crit. Rev. Biochem. 23:1988;233-283.
10. Mannervik B., Awasthi Y.C., Board P.G., Hayes J.D., Di Ilio C., Ketterer B. et al. Nomenclature for human glutathione transferases. Biochem. J. 282:1992;305.
11. Meyer D.J., Coles B., Pemble S.E., Gilmore K.S., Fraser G.M., Ketterer B. θ, a new class of glutathione transferases purified from rat and man. Biochem. J. 274:1991;409.
12. Seidegard J., Vorachek W.R., Pero R.W., Pearson W.R. Hereditary differences in the expression of the human glutathione transferase active in trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. USA. 85:1998;7293.
13. Pemble S., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M. et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochemical. J. 300:1994;271.
14. Watson M.A., Stewart R.K., Smith G.B.J., Massey T.E., Bell D.A. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 19:1998;275.
15. Chen H., Sandler D.P., Taylor J.A., Shore D.L., Liu E., Bloomfield C.D. et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet. 347:1996;295.
16. Basu T., Gale R.E., Langabeer S., Linch D.C. Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukemia. Lancet. 349:1997;1450.
17. Atoyebi W., Kusec R., Fidler C., Peto T.E.A., Boultwood J., Wainscoat J.S. Glutathione S-transferase gene deletion in myelodysplasia. Lancet. 347:1997;1450.
18. Preudhomme C., Nisse C., Hebbar M., Vanrumbeke M., Brizard A., Lai J.L. et al. Glutathione S transferase theta 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens. Leukemia. 11:1997;1580.
19. Okada M., Okamoto T., Wada H., Tademoto Y., Kakishita E. Glutathione S-transferase theta 1 gene (GSTT1) defect in Japanese patients with myelodysplastic syndromes. Int. J. Hematol. 66:1997;393.
20. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R. et al. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51:1982;189.
21. Brito-Babapulle F., Catovsky D., Galton D.A. Clinical and laboratory features of de novo acute myeloid leukemia with triliniage myelodysplasia. Br. J. Haematol. 66:1987;445.
22. Horiike S., Misawa S., Nakai H., Kaneko H., Yokota S., Taniwaki M. et al. N-ras mutation and karyotypic evolution are closely associated with leukemia transformation in myelodysplastic syndrome. Leukemia. 8:1994;1331.
23. Kaneko H., Misawa S., Horiike S., Nakai H., Kashima K. TP53 mutations emerge at early phase of myelodysplastic syndrome are associated with complex chromosomal abnormalities. Blood. 85:1995;2189.
24. Chen C.L., Liu Q., Relling M.V. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics. 6:1996;187.
25. Nelson H.H., Wiencke J.K., Christiani D.C., Cheng T.J., Zuo Z.F., Schwartz B.S. et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis. 16:1995;1243.
26. Altshuler D., Kruglyak L., Lander E. Genetic polymorphism and disease. N. Engl. J. Med. 28:1998;1626.
27. Kihara M., Kihara M., Noda K., Okamoto N. Increased risk of lung cancer in Japanese smokers with class mu glutathione S-transferase gene deficiency. Cancer Lett. 71:1993;151.
28. Kelsey K.T., Wiencke J.K. Growing pains for the environmental genetic of breast cancer: observations on a study of the glutathione s-transferases. J. Natl. Cancer Inst. 90:1998;484.
29. Helzlsouer K.J., Selmin O., Huang H.Y., Strickland P.T., Hoffman S., Alberg A.J. et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J. Natl. Cancer Inst. 90:1998;512.
30. Haegerty A.H.M., Fitzgerald D., Smith A., Bowers B., Jones P., Fryer A.A. et al. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumors. Lancet. 343:1994;266.
31. Chen C.L., Liu Q., Pui C.H., Rivera G.K., Sadlund J.T., Ribeiro R. et al. Higher frequency of glutathione S-transferase deletions in Black children with acute lymphoblastic leukemia. Blood. 89:1997;1701.
32. Harries L.W., Stubbins M.J., Forman G., Howard G.C.W., Wolf C.R. et al. Identification of genetic polymorphism at the glutathione S-transferase Pi locus and association with suseptibility to bladder, testicular and prostate cancer. Carcinogenesis. 18:1997;641.
33. Misawa S., Horiike S. TP53 mutations in myelodysplastic syndrome. Leuk. Lymphoma. 23:1996;417.
34. Horiike S., Taniwaki M., Misawa S., Abe T. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer. 62:1988;1129.
35. Wiencke J.K., Pemble S., Ketterer B., Kelsey K.T. Gene deletion of glutathione S-transferase θ: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol. Biomark. Prev. 4:1995;253.
36. Esteller M., Corn P.G., Gabrielson E., Baylin S.B., Herman J.G. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res. 58:1998;4515.